Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 30 out of 100. Risk factors

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

Abstract Background Older Black Americans are twice as likely to have Alzheimer’s Disease or another dementia, and 65% of Black Americans say that they know somebody with Alzheimer’s or dementia. More locally, according to Ohio county level estimates, 11.3% of Ohioans aged 65 are currently living with Alzheimer’s Disease. Higher than the national average 10.7% Method A small sample size of Black Ohioans from different counties took a questionnaire pertaining to information as it relates to Alzheimer’s Disease and other dementia in the Black Communities in Ohio. Result 82% of Black Ohioans surveyed know someone who has been diagnosed with Alzheimer’s Disease or related dementia. 64% of Black Ohioans do not believe cognitive decline issues are a part of normal aging. Only 35% of Black Ohioans surveyed say they are very knowledgeable about dementia. 87% of Black Ohioans surveyed are concerned about developing Alzheimer’s. 94% of Black Ohioans surveyed believe that the lack of access to resources is a reason why Black Americans are more likely to be diagnosed with Alzheimer’s Disease. 62% of Black Ohioans surveyed say they would consider participating in clinical trial concerning Alzheimer’s and/or related dementias if provided more information. 94% recorded that they have not (in the last 6 months) become aware of any elected officials creating or advocating for any legislation concerning cognitive care or dementia support and treatment. 52% believe dementia care, support and treatment should be a priority for elected officials. Conclusion Black Ohioans are concerned about the rising prevalence of Alzheimer’s Disease, however social barriers that prevent equitable access to care, support and treatment is of overwhelming concern. Additionally, Black Ohioans are interested in participating in clinical trials but due to the lack of resourceful information presented and/or provided concerning clinical trials to Black communities, further creates reluctance to participate. Lastly, more than half of the Black Ohioans surveyed are simply unaware of the public policy issues and priorities concerning cognitive decline, but would like for elected officials (federal, state and local) to be more intentional about utilizing public policy to build a better dementia infrastructure for those affected by Alzheimer’s Disease and other dementias.

What this study adds

Evidence grade: Low

In a small survey of Black Ohioans, 82% knew someone diagnosed with Alzheimer's disease or related dementia, 87% were concerned about developing it, and 94% believed lack of access to resources explains higher diagnosis rates among Black Americans. Reported effect size: 11.3%; 10.7%.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Harris, C. J. (2024). The Psychosocial Analyzation of Alzheimer’s Disease and other Dementia among Black Ohioans. Alzheimer s & Dementia. https://doi.org/10.1002/alz.090376

Vancouver

Harris CJ. The Psychosocial Analyzation of Alzheimer’s Disease and other Dementia among Black Ohioans. Alzheimer s & Dementia. 2024. doi:10.1002/alz.090376.

BibTeX

@article{harris2024-aa323b3e,
  author  = {Harris, Camren J},
  title   = {{The Psychosocial Analyzation of Alzheimer’s Disease and other Dementia among Black Ohioans}},
  journal = {Alzheimer s \& Dementia},
  year    = {2024},
  doi     = {10.1002/alz.090376},
  url     = {https://doi.org/10.1002/alz.090376}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

In a small survey of Black Ohioans, 82% knew someone diagnosed with Alzheimer's disease or related dementia, 87% were concerned about developing it, and 94% believed lack of access to resources explains higher diagnosis rates among Black Americans. Only 35% said they were very knowledgeable about dementia.

Study details

How this study scored 30/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 0 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 29 of the 96 points it could be judged on, which is 30 of 100. Total 30 of 100.29 of the 96 points we could judge = 30 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 29 of the 96 points we could judge it on, which is 30 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2024 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 4 year(s) since 2024
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Camren J Harris holds only 2 work(s), too few to judge a track record — left out of this score
Institution's track record 0 / 3 Alzheimer's Association: institution h-index 250 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 29 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 29 of the 96 points we could judge it on is 30 out of 100.
Total 30 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Risk factors from nearby years

Also in Risk factors

389 studies in the library are filed under Risk factors with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk factors hub.

Similar studies

More on Risk factors

See all studies in Risk factors →